Global Recombinant DNA Technology Market Report and Forecast 2024-2032

Global Recombinant DNA Technology Market Outlook

The global recombinant DNA Technology market attained a value of about USD 740.66 billion in 2023. The market is further expected to grow in the forecast period of 2024-2032 at a CAGR of 6.8% to reach nearly USD 1338.54 billion by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Advancements in Technology Owing to Research and Development (R&D) is Expected to Augment the Market Growth

The growing research and development (R&D) activities to treat life threatening diseases like cancer, diabetes, and other  immunodeficiency diseases are expected to augment the market growth of recombinant DNA technology. Technology in collaboration with medicine has made it possible to treat diseases by inserting new or healthy genes in replacement of damaged or diseased genes in the human body. Recombinant DNA technology has allowed scientists to treat diabetes by developing human insulin by using bacteria as the host cell, with the drug produced through microbes thought to be more efficient than the traditional drug. Such developments are expected to aid the market growth. Moreover, advancements in recombinant technologies have also led to the development of gene therapies, used in the treatment of genetic diseases, which is further anticipated to bolster the recombinant DNA industry in the coming years.

Growing Use of Recombinant DNA Technology to Produce Transgenic Animals to Aid the Market Growth

The recombinant DNA technology can be applied to animals to produce transgenic animals. Transgenic animals provide tremendous opportunities to study gene regulation and disease. This is expected to strengthen the research and development (R&D) sector and, thereby, aid the market growth of recombinant DNA technology. Transgenic animals may be genetically modified for the production of pharmaceuticals and vaccine, thus, bolstering industrial demand for recombinant DNA technology due to a heightened demand for effective vaccines and new drugs globally.

Recombinant DNA Technology : Market Segmentation

Recombinant DNA technology (rDNA), also known as genetic engineering, is the technique in which the DNA is cut into small fragments and the joined together with different fragments taken from different organisms to form a recombinant DNA.  It comprises altering genetic material outside an organism to obtain desired and enhanced results in living organisms.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on product, the market is divided into:

• Medical 
• Therapeutic Agent
• Human Protein
• Vaccine
• Non-Medical
• Biotech Crops
• Speciality Chemicals
• Others

On the basis of component, the market is segmented into:

• Expression System
• Mammalian
• Bacteria
• Yeast
• Baculovirus/Insect
• Cloning Vector

Based on application, the market is divided into:

• Food and Agriculture
• Health and Disease
• Human
• Animal
• Environment
• Others

On the basis of end use, the market is categorised into:

• Biotechnology and Pharmaceutical Companies
• Academic and Government Research Institutions
• Others

The EMR report looks into the regional markets of recombinant DNA technology like North America, Europe, Latin America, the Asia Pacific, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Use of Recombinant DNA technology in Food & Agricultural Sector to Surge Industrial Growth

Recombinant DNA technology has shown promising results in the agricultural sector in the production of genetically modified crops. The wide availability of genetically modified foods in the market owing to increased overall production of crops  and reduced used of herbicides and insecticides used by farmers has been strengthening the market growth of recombinant DNA technology. The technology has introduced herbicide bacterial genes into the DNA of certain crops like wheat, soybean, cotton, and rice, making the plant resistant to weeds and insects and making the yield toxic free. This is supporting agricultural productivity and, thus, increasing the demand for recombinant DNA technology. The added benefit of reduced costs with the use of recombinant DNA technology in the agricultural sector is expected to further propel the industrial growth.

Moreover, the cultivation of vitamin-A rich golden rice using recombinant DNA technology to treat malnourished children is expected to further invigorate the market growth in the coming years. Further, with the rising research and development activities related to genetically modified crops, these crops can possess the ability to withstand adverse environmental conditions, such as drought and extreme heat conditions. This is anticipated to provide further growth opportunities for the recombinant DNA technology industry, especially with the growing concerns about climate change and global warming.

Key Industry Players in the Global Recombinant DNA Technology Market

The report presents a detailed analysis of the following key players in the global recombinant DNA technology market, looking into their capacity, market share, and latest developments like capacity expansions, plant turnabouts and mergers and acquisitions.

• Sanofi
• Amgen Inc.
• Genentech Inc.
• GenScript
• Profacgen
• Others

The comprehensive report looks at the micro and macro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of the Porter’s Five Forces Model.

Key Highlights of the Report